Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Consumer Healthcare has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, August 7, 2018 at 18:00 hours at Conference Room, GlaxoSmithKline Consumer Healthcare Limited, Patiala Road, Nabha -147201, to consider and take on record the unaudited Financial Results for the quarter ended June 30, 2018 with Limited Review by Auditors.
The above information is a part of company’s filings submitted to BSE.